Johnson & Johnson

Arkansas to Ask Court to Reconsider Drug Fine
Arkansas Attorney General Dustin McDaniel said Thursday he plans to ask the state Supreme Court to reconsider its decision tossing out a $1.2 billion judgment against drugmaker Johnson & Johnson over the marketing of the antipsychotic drug Risperdal.
NJ Reaches Lawsuit Settlement With Johnson & Johnson
New Jersey will get roughly $18 million from a national settlement resolving allegations that Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., engaged in unlawful marketing practices to promote sales of their antipsychotic drugs Risperdal and Invega.
Hepatitis C Drug Approved by FDA Panel
An experimental hepatitis C drug from Johnson & Johnson has won unanimous support from government advisers who say the medication should be approved to treat patients infected with the liver-destroying virus.
J&J Tries New Cap to Curb Fatal Tylenol Overdoses
Bottles of Tylenol sold in the U.S. will soon bear red warnings alerting users to the potentially fatal risks of taking too much of the popular pain reliever. The unusual step, disclosed by the company that makes Tylenol, comes amid a growing number of lawsuits and pressure from the federal governme…

Load More Articles